Cargando…
MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells
Endometrial cancer is the most common malignancy of the female genital tract. Progesterone (P4) has been used for several decades in endometrial cancer treatment, especially in women who wish to retain fertility. However, it is unpredictable which patients will respond to P4 treatment and which may...
Autores principales: | Yoo, Jung-Yoon, Yang, Woo Sub, Lee, Jae Hee, Kim, Byung Gak, Broaddus, Russell R., Lim, Jeong M., Kim, Tae Hoon, Jeong, Jae-Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764811/ https://www.ncbi.nlm.nih.gov/pubmed/28925396 http://dx.doi.org/10.1038/onc.2017.335 |
Ejemplares similares
-
The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression
por: Kim, Tae Hoon, et al.
Publicado: (2010) -
MIG-6 suppresses endometrial epithelial cell proliferation by inhibiting phospho-AKT
por: Yoo, Jung-Yoon, et al.
Publicado: (2018) -
MIG-6 Is Critical for Progesterone Responsiveness in Human Complex Atypical Hyperplasia and Early-Stage Endometrial Cancer
por: Jeong, Olivia, et al.
Publicado: (2022) -
Loss of MIG-6 results in endometrial progesterone resistance via ERBB2
por: Yoo, Jung-Yoon, et al.
Publicado: (2022) -
Mig-6 Plays a Critical Role in the Regulation of Cholesterol Homeostasis and Bile Acid Synthesis
por: Ku, Bon Jeong, et al.
Publicado: (2012)